Research Development - Vaxart Inc (NASDAQ:VXRT) - Alpha Spread

Vaxart Inc
NASDAQ:VXRT

Watchlist Manager
Vaxart Inc Logo
Vaxart Inc
NASDAQ:VXRT
Watchlist
Price: 0.8344 USD -7.91% Market Closed
Market Cap: 189.8m USD
Have any thoughts about
Vaxart Inc?
Write Note

Vaxart Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vaxart Inc
Research & Development Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Vaxart Inc
NASDAQ:VXRT
Research & Development
-$66.2m
CAGR 3-Years
-25%
CAGR 5-Years
-32%
CAGR 10-Years
-15%
Abbvie Inc
NYSE:ABBV
Research & Development
-$7.5B
CAGR 3-Years
-2%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Research & Development
-$5.7B
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Research & Development
-$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Research & Development
-$3.4B
CAGR 3-Years
-7%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Research & Development
-$4.7B
CAGR 3-Years
-18%
CAGR 5-Years
-13%
CAGR 10-Years
-16%

See Also

What is Vaxart Inc's Research & Development?
Research & Development
-66.2m USD

Based on the financial report for Jun 30, 2024, Vaxart Inc's Research & Development amounts to -66.2m USD.

What is Vaxart Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-15%

Over the last year, the Research & Development growth was 19%. The average annual Research & Development growth rates for Vaxart Inc have been -25% over the past three years , -32% over the past five years , and -15% over the past ten years .

Back to Top